Kayoko Tsujino Selected Research

Kayoko Tsujino Research Topics

12	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 08/2011
12	Neoplasms (Cancer) 11/2022 - 01/2003
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 11/2007
4	Radiation Pneumonitis 07/2020 - 03/2006
4	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2003
3	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2005
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2021 - 03/2006
3	Neoplasm Metastasis (Metastasis) 09/2021 - 01/2019
2	Adenocarcinoma 08/2022 - 08/2010
2	Carcinoma (Carcinomatosis) 05/2022 - 05/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021 - 01/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2020 - 01/2020
1	Unconsciousness (Loss of Consciousness) 01/2023
1	Lymphedema (Milroy Disease) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Adenosquamous Carcinoma 08/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2021
1	Disease Progression 01/2021
1	Febrile Neutropenia 09/2016
1	Leukopenia 09/2016
1	Neutropenia 09/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Stress Fractures (Stress Fracture) 11/2013
1	Pneumonia (Pneumonitis) 02/2013
1	Glioblastoma (Glioblastoma Multiforme) 08/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2009
1	Vomiting 01/2009
1	Brain Neoplasms (Brain Tumor) 06/2006
1	Esophageal Neoplasms (Esophageal Cancer) 03/2006
1	Margins of Excision 01/2005
1	Fibrosis (Cirrhosis) 03/2002

2	durvalumabIBA 11/2023 - 01/2021
2	squamous cell carcinoma-related antigenIBA 01/2021 - 12/2019
2	Cisplatin (Platino)FDA LinkGeneric 09/2016 - 03/2016
2	Carboplatin (JM8)FDA LinkGeneric 02/2013 - 05/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2013 - 05/2012
1	Apolipoprotein C-II (ApoC2)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Apolipoproteins C (ApoC)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	LigandsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	C-Reactive ProteinIBA 07/2020
1	Tumor Biomarkers (Tumor Markers)IBA 12/2019
1	TitaniumIBA 11/2019
1	Shape Memory AlloysIBA 11/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2016
1	Etoposide (VP 16)FDA LinkGeneric 03/2016
1	amrubicinIBA 03/2016
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	NimustineIBA 08/2010
1	Fluorouracil (Carac)FDA LinkGeneric 01/2009
1	doranidazoleIBA 11/2007
1	taxaneIBA 01/2003
1	PlatinumIBA 01/2003
1	A-factor (Streptomyces)IBA 01/2003

30	Radiotherapy 11/2023 - 03/2006
12	Chemoradiotherapy 11/2023 - 11/2007
11	Brachytherapy 01/2023 - 08/2010
9	Drug Therapy (Chemotherapy) 09/2021 - 01/2003
4	Therapeutics 12/2019 - 01/2005
1	Deep Sedation 01/2023
1	Conservative Treatment 11/2022
1	Aftercare (After-Treatment) 08/2022
1	Cranial Irradiation 09/2021
1	Proton Therapy 04/2021
1	Adjuvant Chemotherapy 07/2020
1	Salvage Therapy 12/2019
1	Particle Accelerators 01/2014
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2014
1	Consolidation Chemotherapy 05/2012
1	Conformal Radiotherapy 05/2012
1	Induction Chemotherapy 11/2007
1	Segmental Mastectomy (Lumpectomy) 01/2005
1	Neck Dissection (Radical Neck Dissection) 03/2002